Get started
Author

Damien Eggenspieler

Observed names: D. Eggenspieler, Eggenspieler, D.
Institution: Sysnav (France)
OpenAlex ID: A5086234527
Deterministic Order in Surface Micro‐Topologies through Sequential Wrinkling
2012 · Jie Yin, Jose Luis Yagüe, et al. · Advanced Materials · 153
First Regulatory Qualification of a Novel Digital Endpoint in Duchenne Muscular Dystrophy: A Multi-Stakeholder Perspective on the Impact for Patients and for Drug Development in Neuromuscular Diseases
2021 · Laurent Servais, Eric Camino, et al. · Digital Biomarkers · 77
PDF
Evolving regulatory perspectives on digital health technologies for medicinal product development
2023 · Seya Colloud, Thomas Metcalfe, et al. · npj Digital Medicine · 57
PDF
First regulatory qualification of a digital primary endpoint to measure treatment efficacy in DMD
2023 · Laurent Servais, Damien Eggenspieler, et al. · Nature Medicine · 40
PDF
Evidentiary basis of the first regulatory qualification of a digital primary efficacy endpoint
2024 · Laurent Servais, Paul Strijbos, et al. · Scientific Reports · 27
PDF
Normative data on spontaneous stride velocity, stride length, and walking activity in a non-controlled environment
2021 · Margaux Poleur, Ana Ulinici, et al. · Orphanet Journal of Rare Diseases · 24
PDF
Stride Velocity 95 th Centile Detects Decline in Ambulatory Function Over Shorter Intervals than the 6-Minute Walk Test or North Star Ambulatory Assessment in Duchenne Muscular Dystrophy
2024 · Michael Rabbia, Maitea Guridi Ormazabal, et al. · Journal of Neuromuscular Diseases · 18
PDF
Reverse Engineering of Digital Measures: Inviting Patients to the Conversation
2023 · Ieuan Clay, Nele Peerenboom, et al. · Digital Biomarkers · 16
E-Health & Innovation to Overcome Barriers in Neuromuscular Diseases. Report from the 1st eNMD Congress: Nice, France, March 22-23, 2019
2021 · Jonathan Pini, Gabriele Siciliano, et al. · Journal of Neuromuscular Diseases · 7
PDF
Stride-level measurement of gait as an early sensitive marker of disability progression in ambulatory patients with multiple sclerosis
2026 · Margaux Poleur, Barbara Willekens, et al. · EClinicalMedicine · 3
FP.12 Application for primary endpoint qualification of the 95th centile of stride velocity (SV95C) in Duchenne muscular dystrophy
2022 · M. Annoussamy, D. Eggenspieler, et al. · Neuromuscular Disorders · 2
Surface Micropatterning: Deterministic Order in Surface Micro‐Topologies through Sequential Wrinkling (Adv. Mater. 40/2012)
2012 · Jie Yin, Jose Luis Yagüe, et al. · Advanced Materials · 2
Reliability and External Validity of Digital Passive Gait Tracking in MS (P6-6.008)
2024 · Margaux Poleur, Barbara Willekens, et al. · Neurology · 1
PDF
Outcome Measures
2021 · M. Annoussamy, D. Eggenspieler, et al. · Neuromuscular Disorders · 1
Dmd/bmd – Outcome Measures
2021 · M. Poleur, A. Ulinici, et al. · Neuromuscular Disorders · 1
Sma: Registries, Biomarkers & Outcome Measures
2020 · C. Lilien, M. Annoussamy, et al. · Neuromuscular Disorders · 1
Outcome Measures
2020 · M. Annoussamy, D. Eggenspieler, et al. · Neuromuscular Disorders · 1
Real-world Assessment of Ambulatory Function with Wearable Sensors in Patients with Parkinson’s Disease
2026 · M. Michaud, D. d’Haultfoeuille, et al. · Parkinsonism & Related Disorders
1.57eP Continuous real-world assessment of ambulation in amyotrophic lateral sclerosis using digital health technology
2026 · Camila Gonzalez Barral, Margaux Poleur, et al. · Neuromuscular Disorders
2.34P Predicting the 95th centile stride velocity (SV95C) at 6-, 12-, 18-, and 24-months in steroid-treated boys with Duchenne muscular dystrophy
2026 · Georgia Stimpson, Guillaume Parinello, et al. · Neuromuscular Disorders
2.36P “Walk like an Egyptian” Comparing the natural history of Egyptian and European Duchenne muscular dystrophy patients in a prospective multicentre study
2026 · Sherry Kodsy, Areej Saleh, et al. · Neuromuscular Disorders
4.61P Evaluation of ambulatory function with a wearable sensor in myotonic dystrophy type 1
2026 · Margaux Poleur, Stéphanie Delstanche, et al. · Neuromuscular Disorders
Feasibility, Reliability and Clinical Validity of Stride Velocity as a Real-life Digital Outcome in Knee Osteoarthritis
2026 · Camila Gonzalez Barral, Margaux Poleur, et al. · Osteoarthritis and Cartilage
177PLongitudinal stride-level evaluation of ambulatory function with ankle wearable technology in ambulant DMD patients below 4 years old
2025 · M. Poleur, G. Parinello, et al. · Neuromuscular Disorders
414PFeasibility of using a wearable digital health technology sensor to assess ambulation in CMT and DM1
2025 · M. Poleur, S. Delstanche, et al. · Neuromuscular Disorders
Works count: 44
Citation count: 431
H-index: 8
I10-index: 8
Year
Topic
Type